Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2019
activism
acute hepatic porphyria
alnylam pharmaceuticals
bernie sanders
biotech & health
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
celgene
charges
congress
crisis
detroit blog main
detroit top stories
drug prices
easl
fatty liver disease
givosiran
house of representatives
indiana blog main
indiana top stories
indivior
insulin
intercept pharmaceuticals
lawsuit
legal
life sciences
liver
liver congress
m&a
medicare for all
nafld
nash
national
national blog main
What
bio
2
×
major
2
×
accelerating
advanced
alleviate
alnylam’s
approval
area
bff
bounds
cells
clearly
conditions
conference
controversial
controversy
cost
deals
devoted
disease
drug
easl
form
futuristic
gene
generating
grown
hailed
harvesting
human
industrial
investment
involves
kicked
leaps
levels
liver
medical
medicine
method
Language
unset
Current search:
bio
×
major
×
@techcrunch.com
3 months ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More